Several mechanisms of anti-VEGF agents in brain tumors have been proposed such as vascular normalization leading to improved tissue oxygenation and drug delivery, sensitization of endothelial cells to cytotoxic agents specifically radiation, and direct anti-glioma stem cell effect [9,11]. The gene discussed is VEGFA; the disease is central nervous system cancer.